Daratumumab (anti-CD38)Daratumumab (anti-CD38)
Move your mouse over image or click to enlarge

Daratumumab (anti-CD38)

Daratumumab (anti-CD38) is a recombinant monoclonal antibody to CD38. Daratumumab is an investigational anti-cancer drug which is indicated for the treatment of adult patients with multiple myeloma. MW =145.4 kDa.
Cat# Size Price Qty Buy
A2027-5mg 5mg £579.00

Additional Information

Property Value or Rating
Product Size 5mg
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2027

Related Documents